Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7576106 Piperidine derivatives and methods of use

Patent 7576106 was granted and assigned to ChemoCentryx on August, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Edward J. Sullivan0

Penglie Zhang0

Andrew M. K. Pennell0

Wei Chen0

Kevin Lloyd Greenman0

Lianfa Li0

Date of Patent

August 18, 2009

0

Patent Application Number

115802020

Date Filed

October 11, 2006

0

Patent Citations Received

US Patent 11759454 Diazole lactams

US Patent 11744822 Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors

Patent Primary Examiner

0

Patent abstract

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7576106 Piperidine derivatives and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.